BioMed Research International

Volume 2014 (2014), Article ID 308263, 1 page

http://dx.doi.org/10.1155/2014/308263

Retraction

Retracted: Downregulation of ADAM10 Expression Inhibits Metastasis and Invasiveness of Human Hepatocellular Carcinoma HepG2 Cells

BioMed Research International

Received 17 April 2014; Accepted 17 April 2014; Published 29 April 2014

Copyright © 2014 BioMed Research International. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The article titled “Downregulation of ADAM10 Expression Inhibits Metastasis and Invasiveness of Human Hepatocellular Carcinoma HepG2 Cells” [1] has been retracted as it is found to contain a substantial amount of material, without referencing, from the paper “ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells,” by Shao Yuan, Shi Lei, and Shengli Wu published in Oncology Reports, vol. 2013, 1715-1722 pages, DOI: 10.3892/or.2013.2650.

References

Y. Yue, Y. Shao, Q. Luo, L. Shi, and Z. Wang, “Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells,” BioMed Research International, vol. 2013, Article ID 434561, 6 pages, 2013.